FIELD: medicine, pharmacology. SUBSTANCE: invention relates to the novel compositions of chemical formulations, namely, to composition consisting of ten natural amino acids, four trace elements and calcium. Composition shows antitumor, antidepressant and anti-arrhythmic activity and can be used in medicine. Composition has the following components, g/l: valine, 1.00; leucine, 4.40; isoleucine, 2.90; phenylalanine, 4.40; tryptophan, 1.00; lysine hydrochloride, 1.25; methionine, 4.40; histidine, 14.2; serine, 28.6; lithium glutamate, 29.8; and also, mole/l: manganese (II) dichloride, 1.6 x 10-3; cobalt (II) dichloride, 1.5 x 10-5; copper (II) dichloride, 3.7 x 10-4; calcium dichloride, 2.1 x 10-3 and distilled water. Composition of amino acids with trace elements and calcium does not show toxicity practically, shows antiblastic and antidepressant activity and antiarrhythmic effect. EFFECT: valuable curative properties of composition. 6 tbl, 1 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION CONTAINING AMINO ACIDS AND TRACE ELEMENTS AND SHOWING ANTITUMOR AND ANTIHYPOXIC ACTIVITY | 1994 |
|
RU2125874C1 |
COMPOSITION OF AMINO ACIDS WITH TRACE ELEMENTS ELICITING ANTIARRHYTHMIC ACTIVITY | 1999 |
|
RU2173553C2 |
TETRAKIS-(L-HISTIDINATO)-μ-PEROXYDICOBALT)III HEPTAHYDRATE HAVING ANTIANEMIC, RADIOPROTECTIVE AND ANTIARRHYTHMIC ACTIVITIES | 1999 |
|
RU2151773C1 |
L-α-AMINO -γ-LITHIUM METHYLMERCAPTOBUTYRATE HAVING ANTITUMOR AND ANTIULCER ACTIVITY | 1994 |
|
RU2114853C1 |
NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY | 1999 |
|
RU2190618C2 |
BISIMIDAZOLE-(1,10)-PHENENTHROLINE PLATINUM (III) DICHLORIDE SHOWING CYTOSTATIC ANTITUMOR ACTIVITY | 1995 |
|
RU2089555C1 |
BIS-IMIDAZOLE-(1,10)-PHENANTHROLINE COPPER (II) DICHLORIDE SHOWING ANTIBACTERIAL AND ANTIBLASTIC ACTIVITY, METHOD OF ITS SYNTHESIS | 2001 |
|
RU2190616C1 |
PREPARATION FOR TREATMENT OF PATIENT WITH CANCER SKIN AND PRECANCER SKIN DISEASES | 1998 |
|
RU2146927C1 |
AGENT HAVING ANTI-TUMOUR ACTIVITY | 2023 |
|
RU2819039C1 |
DERIVATIVE OF THE CLASS OF N-GLYCOSIDES INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOLE-5,7-DIONE - N-{12-(β-D-XYLOPYRANOSYL)-5,7-DIOXO-INDOLO[2,3-A]PYRROLO[3,4-C]CARBAZOL-6-YL} PYRIDINE-2-CARBOXAMIDE, WHICH HAS CYTOTOXIC AND ANTITUMOR ACTIVITY | 2017 |
|
RU2667906C1 |
Authors
Dates
2000-06-27—Published
1999-03-10—Filed